Mirum Pharmaceuticals, Inc. - common stock (MIRM) stock analysis

MIRM · Mirum Pharmaceuticals, Inc. - common stock

Latest recorded price: USD 91.58

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth 89.1%, free cash flow margin 10.5%.

Similar companies in Healthcare